Stocks
Bristol-Myers (BMY) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 43.4% | 41.6% | 43.0% | 6.56% | 30.2% | 28.4% | ||
| Changes by years, y/y, % | +32pp | -2pp | +1pp | -36pp | +24pp | +20.6% | |||
Bristol-Myers. EBITDA margin, %
Bristol-Myers. EBITDA margin, changes, pp
Bristol-Myers (BMY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 40.0% | 26.8% | 37.5% | 17.5% | 32.3% | 28.4% | |
| Changes by years, y/y, % | +112pp | -9pp | -3pp | -3pp | -8pp | |||
| Changes by quarters, q/q, % | +19pp | -13pp | +11pp | -20pp | +15pp | |||
